iHuman Inc. Sponsored ADR (NYSE:IH – Get Free Report)’s stock price traded down 2.4% during mid-day trading on Monday . The stock traded as low as $1.20 and last traded at $1.22. 9,052 shares changed hands during trading, a decline of 18% from the average daily volume of 11,102 shares. The stock had previously closed at $1.25.
iHuman Stock Performance
The company’s fifty day simple moving average is $1.36 and its two-hundred day simple moving average is $1.58. The stock has a market capitalization of $62.35 million, a PE ratio of 6.42 and a beta of 0.18.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in iHuman stock. Acadian Asset Management LLC purchased a new position in iHuman Inc. Sponsored ADR (NYSE:IH – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 15,067 shares of the company’s stock, valued at approximately $32,000. 4.92% of the stock is currently owned by institutional investors.
About iHuman
iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People’s Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.
Further Reading
- Five stocks we like better than iHuman
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.
